title: Effects of inhaled nitric oxide and aerosolized iloprost in pulmonary veno-occlusive disease.
authors.affiliation: Department of Pulmonary Medicine, Hannover Medical School, Germany. KMHoeper@AOL.com
authors.forename: M M
authors.initials: MM
authors.lastname: Hoeper
authors.forename: C
authors.initials: C
authors.lastname: Eschenbruch
authors.forename: C
authors.initials: C
authors.lastname: Zink-Wohlfart
authors.forename: A
authors.initials: A
authors.lastname: Schulz
authors.forename: S
authors.initials: S
authors.lastname: Markworth
authors.forename: K
authors.initials: K
authors.lastname: Pohl
authors.forename: H
authors.initials: H
authors.lastname: Fabel
mesh_terms: D000280:Administration, Inhalation; D000328:Adult; D000336:Aerosols; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D006801:Humans; D016285:Iloprost / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D009102:Multiple Organ Failure; D009569:Nitric Oxide / Q000008:administration & dosage* / Q000627:therapeutic use; D011668:Pulmonary Veno-Occlusive Disease / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D000336:Aerosols; D014665:Vasodilator Agents; D009569:Nitric Oxide; D016285:Iloprost